Cargando…

Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study

BACKGROUND: Hyperbilirubinemia is one of the common complications after cardiac surgery and is associated with increased mortality. However, to the best of our knowledge, the reports on clinical significance of postoperative severe hyperbilirubinemia in Stanford type A aortic dissection (AAD) patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaolan, Bai, Ming, Zhao, Lijuan, Li, Yangping, Yu, Yan, Zhang, Wei, Ma, Feng, Sun, Shiren, Chen, Xiangmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388495/
https://www.ncbi.nlm.nih.gov/pubmed/32723390
http://dx.doi.org/10.1186/s13019-020-01243-7
_version_ 1783564321529266176
author Chen, Xiaolan
Bai, Ming
Zhao, Lijuan
Li, Yangping
Yu, Yan
Zhang, Wei
Ma, Feng
Sun, Shiren
Chen, Xiangmei
author_facet Chen, Xiaolan
Bai, Ming
Zhao, Lijuan
Li, Yangping
Yu, Yan
Zhang, Wei
Ma, Feng
Sun, Shiren
Chen, Xiangmei
author_sort Chen, Xiaolan
collection PubMed
description BACKGROUND: Hyperbilirubinemia is one of the common complications after cardiac surgery and is associated with increased mortality. However, to the best of our knowledge, the reports on clinical significance of postoperative severe hyperbilirubinemia in Stanford type A aortic dissection (AAD) patients were limited. METHODS: Patients who underwent surgical treatment for AAD in our center between January 2015 and December 2018 were retrospectively screened. In-hospital mortality, long-term mortality, acute kidney injury (AKI), and the requirement of continuous renal replacement therapy (CRRT) were assessed as endpoints. Univariate and multivariate regression models were employed to identify the risk factors of these endpoints. RESULTS: After screening, 271 patients were included in our present study. Of the included patients, 222 (81.9%) experienced postoperative AKI, and 50 (18.5%) received CRRT. The in-hospital mortality was 30.3%. The 1-year, 2-year, and 3-year cumulative mortality were 32.9, 33.9, and 35.3%, respectively. Multivariate Logistic regression analysis indicated that age (P < 0.033), AKI stage 3 (P < 0.001), the amount of blood transfusion after surgery (P = 0.019), mean arterial pressure (MAP) in the first postoperative day (P = 0.012), the use of extracorporeal membrane oxygenation (ECMO) (P = 0.02), and the peak total bilirubin (TB) concentration (P = 0.023) were independent risk factors of in-hospital mortality. The optimal cut-off value of peak TB on predicting in-hospital mortality was 121.2 μmol/L. Patients with post-operation TB ≥ 121 μmol/L was associated with worse long-term survival as well. CONCLUSIONS: Severe post-operation hyperbilirubinemia is a common clinical situation in patients had AAD repair. In AAD patients with severe post-operation hyperbilirubinemia, older age, lower MAP, increased blood transfusion, stage 3 AKI, the use of ECMO, and the increased peak TB lead to increase in-hospital mortality.
format Online
Article
Text
id pubmed-7388495
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-73884952020-07-31 Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study Chen, Xiaolan Bai, Ming Zhao, Lijuan Li, Yangping Yu, Yan Zhang, Wei Ma, Feng Sun, Shiren Chen, Xiangmei J Cardiothorac Surg Research Article BACKGROUND: Hyperbilirubinemia is one of the common complications after cardiac surgery and is associated with increased mortality. However, to the best of our knowledge, the reports on clinical significance of postoperative severe hyperbilirubinemia in Stanford type A aortic dissection (AAD) patients were limited. METHODS: Patients who underwent surgical treatment for AAD in our center between January 2015 and December 2018 were retrospectively screened. In-hospital mortality, long-term mortality, acute kidney injury (AKI), and the requirement of continuous renal replacement therapy (CRRT) were assessed as endpoints. Univariate and multivariate regression models were employed to identify the risk factors of these endpoints. RESULTS: After screening, 271 patients were included in our present study. Of the included patients, 222 (81.9%) experienced postoperative AKI, and 50 (18.5%) received CRRT. The in-hospital mortality was 30.3%. The 1-year, 2-year, and 3-year cumulative mortality were 32.9, 33.9, and 35.3%, respectively. Multivariate Logistic regression analysis indicated that age (P < 0.033), AKI stage 3 (P < 0.001), the amount of blood transfusion after surgery (P = 0.019), mean arterial pressure (MAP) in the first postoperative day (P = 0.012), the use of extracorporeal membrane oxygenation (ECMO) (P = 0.02), and the peak total bilirubin (TB) concentration (P = 0.023) were independent risk factors of in-hospital mortality. The optimal cut-off value of peak TB on predicting in-hospital mortality was 121.2 μmol/L. Patients with post-operation TB ≥ 121 μmol/L was associated with worse long-term survival as well. CONCLUSIONS: Severe post-operation hyperbilirubinemia is a common clinical situation in patients had AAD repair. In AAD patients with severe post-operation hyperbilirubinemia, older age, lower MAP, increased blood transfusion, stage 3 AKI, the use of ECMO, and the increased peak TB lead to increase in-hospital mortality. BioMed Central 2020-07-28 /pmc/articles/PMC7388495/ /pubmed/32723390 http://dx.doi.org/10.1186/s13019-020-01243-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Chen, Xiaolan
Bai, Ming
Zhao, Lijuan
Li, Yangping
Yu, Yan
Zhang, Wei
Ma, Feng
Sun, Shiren
Chen, Xiangmei
Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study
title Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study
title_full Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study
title_fullStr Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study
title_full_unstemmed Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study
title_short Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study
title_sort characteristics and outcomes of stanford type a aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388495/
https://www.ncbi.nlm.nih.gov/pubmed/32723390
http://dx.doi.org/10.1186/s13019-020-01243-7
work_keys_str_mv AT chenxiaolan characteristicsandoutcomesofstanfordtypeaaorticdissectionpatientswithseverepostoperationhyperbilirubinemiaaretrospectivecohortstudy
AT baiming characteristicsandoutcomesofstanfordtypeaaorticdissectionpatientswithseverepostoperationhyperbilirubinemiaaretrospectivecohortstudy
AT zhaolijuan characteristicsandoutcomesofstanfordtypeaaorticdissectionpatientswithseverepostoperationhyperbilirubinemiaaretrospectivecohortstudy
AT liyangping characteristicsandoutcomesofstanfordtypeaaorticdissectionpatientswithseverepostoperationhyperbilirubinemiaaretrospectivecohortstudy
AT yuyan characteristicsandoutcomesofstanfordtypeaaorticdissectionpatientswithseverepostoperationhyperbilirubinemiaaretrospectivecohortstudy
AT zhangwei characteristicsandoutcomesofstanfordtypeaaorticdissectionpatientswithseverepostoperationhyperbilirubinemiaaretrospectivecohortstudy
AT mafeng characteristicsandoutcomesofstanfordtypeaaorticdissectionpatientswithseverepostoperationhyperbilirubinemiaaretrospectivecohortstudy
AT sunshiren characteristicsandoutcomesofstanfordtypeaaorticdissectionpatientswithseverepostoperationhyperbilirubinemiaaretrospectivecohortstudy
AT chenxiangmei characteristicsandoutcomesofstanfordtypeaaorticdissectionpatientswithseverepostoperationhyperbilirubinemiaaretrospectivecohortstudy